STAT3 is widely recognized as a therapeutic target in multiple cancers and has been shown to transcriptionally regulate key effector proteins such as cyclin D1, vimentin, and survivin, which are critically involved in cell proliferation, migration, and apoptosis (Chen et al., 2020; Yang et al., 2019; Kuo et al., 2022). This evidence concerns the gene STAT3 and cancer.